Loading...

Nuwellis, Inc.

NUWENASDAQ
HealthcareMedical - Devices
$0.41
$-0.20(-33.06%)

Nuwellis, Inc. (NUWE) Stock Overview

Explore Nuwellis, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Revenue Growth
-1.40%
1.40%
Profit Growth
$-6.76
47.43%
EPS Growth
$-6.76
97.66%
Operating Margin
-105.83%
37.67%
ROE
-610.07%
47.43%
Dividend Yield
0.00%

Analyst Recommendations

Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0

Price Targets

Low$0.00
Average$0.00
High$0.00

Company Profile

Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics. Its Aquadex FlexFlow system includes a console, disposable blood set, and catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors primarily in Austria, Brazil, Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.

CEO

Mr. John L. Erb

Employees

38

Headquarters

12988 Valley View Road, Eden Prairie, MN

Founded

2012

Frequently Asked Questions